Immunoglobulin kappa variable 3-34 (IGKV3-34)

Immunoglobulin kappa variable 3-34 (IGKV3-34) is a gene segment that encodes one of the variable regions used in the light chain of antibodies (kappa light chain) in humans[2][5]. The human antibody variable regions are assembled from multiple gene segments (V, J, and—if heavy chain—D) during B cell development through a process called V(D)J recombination[4]. IGKV3-34 refers specifically to a variable region segment on chromosome 2, which combines with other immunoglobulin gene segments to generate the enormous diversity of antibody specificities in the adaptive immune response[3][4][5]. IGKV3-34 per se is not a target for drugs and not a receptor, enzyme, or other classical druggable protein, but rather a genetic template incorporated into mature immunoglobulin molecules as part of normal or sometimes pathologic immune responses[2][3][5]. In clinical immunology, variable region gene usage, including IGKV3-34, has been studied for its association with autoimmune disorders and certain B cell malignancies, based on biased usage patterns seen in these conditions, but IGKV3-34 is not itself a receptor or an actionable therapeutic target[2][3]. Additional context: - IGKV3-34 is sometimes annotated as a pseudogene (non-functional gene fragment) in some individuals, but functional alleles encoding variable regions do exist and are used in B cell development[1][2][5]. - It is not a receptor and does not act in signal transduction as a standalone protein; rather, it contributes to the diversity of antibody binding sites[3][4]. - No therapeutics are designed to interact with IGKV3-34 itself; therapies target pathogenic antibodies where this gene segment may have been incorporated. The principal limitation is that IGKV3-34 is a gene segment, not a therapeutic target or receptor, and is best classified as a genetic element contributing to antibody diversity rather than a standalone protein target[2][3][4][5].

Other names

IGKV3-34IGKV334O17